SpePharm

About SpePharm

Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a robust global network of partnerships. The company focuses on acquiring, developing, and commercializing innovative medicines that significantly improve patient outcomes. Norgine operates in multiple specialist therapy areas, including gastroenterology and hepatology, serving millions of patients worldwide annually. The company's business model is built on agility and adaptability, enabling it to collaborate with partners through various means such as licensing, acquisitions, and special purpose vehicles (SPVs). Norgine's infrastructure supports these partnerships, allowing for efficient development and distribution of its products. With over 1,500 employees, Norgine leverages its extensive expertise and resources to reinvest in future medical advancements. The company's strong financial performance, evidenced by its million net product sales in 2020, underscores its capability to sustain growth and innovation in the pharmaceutical sector.